Search

Author/Creator Dellinger, Ryan W.

1. Efficacy and tolerability of EH301 for amyotrophic lateral sclerosis: a randomized, double-blind, placebo-controlled human pilot study. Issue 1 (2nd January 2019)

Authors:
de la Rubia, JosÉ E.; Drehmer, Eraci; Platero, JosÉ L.; Benlloch, MarÍa; Caplliure-Llopis, Jordi; Villaron-Casales, Carlos; de Bernardo, Nieves; AlarcÓn, Jorge; Fuente, Cristian; Carrera, Sandra; Sancho, David; GarcÍa-Pardo, Pilar; Pascual, Raquel; JuÁrez, Marta; Cuerda-Ballester, María; Forner, ...
Journal:
Amyotrophic lateral sclerosis and frontotemporal degeneration
Issue:
Volume 20:Issue 1/2(2019)
Page Start:
115
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Safety Assessment of High-Purity, Synthetic Nicotinamide Riboside (NR-E) in a 90-Day Repeated Dose Oral Toxicity Study, With a 28-Day Recovery Arm. (July 2020)

Authors:
Marinescu, Anca G.; Chen, Jayson; Holmes, Holly E.; Guarente, Leonard; Mendes, Odete; Morris, Mark; Dellinger, Ryan W.
Journal:
International journal of toxicology
Issue:
Volume 39:Number 4(2020)
Page Start:
307
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗